Updated: May 8, 2008
Lipomas are benign tumors composed of mature fat cells. They are the most common benign mesenchymal tumor. Lipomas are found in the subcutaneous tissues and, less commonly, in internal organs. They usually present with little difficulty in diagnosis or morbidity. Lipomas typically develop as discrete rubbery masses in the subcutaneous tissues of the trunk and proximal extremity. They usually are a few centimeters in size and can be removed by surgical excision or liposuction.
The eMedicine general surgery article Lipomas may be of interest, as may the Medscape Dermatologic Surgery Resource Center.
Lipomas differ biochemically from normal fat by demonstrating increased levels of lipoprotein lipase and by the presence of a larger number of precursor cells.
Approximately 60% of solitary cutaneous lipomas display clonal alterations. The most common alteration involves a breakpoint on bands 12q13-15. Karyotype aberrations also have been noted on arms 6p and 13q. Multiple lipomas do not display these alterations.
In one study in a Scandinavian population, 43% of benign mesenchymal tumors were lipomas.
No fatalities are reported with cutaneous lipomas. Mild tenderness occasionally is associated with the tumors. Angiolipomas often are tender.
Solitary lipomas are seen predominately in women. Multiple lipomas occur more frequently in men.
Lipomas can occur at any age; however, they usually arise in early adulthood and are rare in children and infants.
Patients usually give a history of a slowly growing lesion present for several years and usually do not complain of discomfort. Lipomas are classified in the following categories:
Blue Rubber Bleb Nevus Syndrome
Dermatofibroma
Glomus Tumor
Leiomyoma
Hibernomas
Lipoblastomas
Liposarcomas
Neurofibromas
Epidermoid cysts (occasionally)
Lipomas histologically resemble normal fat. When completely excised, a thin fibrous capsule surrounding the aggregate of adipocytes may be seen. Without a clinical or gross description, it often is impossible to distinguish between tumor cells and mature adipocytes.
Lipomas differ biochemically from normal mature fat. Lipomas have increased levels of lipoprotein lipase.
Surgical techniques typically are used; however, Dercum disease also has been treated medically using intravenous infusions of lidocaine,2 steroids, and analgesic medications. Topical EMLA (eutectic mixture of lidocaine and prilocaine in a ratio of 1:1 by weight) also has been used for Dercum disease.3 Intravenous use of lidocaine can be effective for Dercum disease; however, adverse effects typically outweigh benefits.
Mesotherapy4,5 is a treatment for body conturing that has been used for many years in Europe. Mesotherapy involves a series of injections containing many different ingredients, including vasodilators, nonsteroidal anti-inflammatory drugs, enzymes, and hormones. A common chemical used is lecithin (phosphatidylcholine isoproterenol), a lipolytic agent. However, a recent study has shown that when lecithin solubilized with deoxycholate was used to treat subcutaneous lipomas, the active ingredient was actually the deoxycholate rather than the phosphatidalcholine.6 This study suggested that low-concentration deoxycholate may be a safe and effective treatment for small collections of fat. While more study is needed, mesotherapy may one day be the treatment of choice for certain lipomas.
Multiple surgical techniques can treat lipomas. Carefully evaluate infiltrating lipomas when considering excision, since they can develop in intramuscular or intermuscular locations. They also can infiltrate into tendon, bone, and nerve, thus requiring careful microdissection to preserve important structures.
Wolfe SW, Bansal M, Healey JH, Ghelman B. Computed tomographic evaluation of fatty neoplasms of the extremities. A clinical, radiographic, and histologic review of cases. Orthopedics. Oct 1989;12(10):1351-8. [Medline].
Juhlin L. Long-standing pain relief of adiposis dolorosa (Dercum's disease) after intravenous infusion of lidocaine. J Am Acad Dermatol. Aug 1986;15(2 Pt 2):383-5. [Medline].
Reggiani M, Errani A, Staffa M, Schianchi S. Is EMLA effective in Dercum's disease?. Acta Derm Venereol. Mar 1996;76(2):170-1. [Medline].
Matarasso A, Pfeifer TM. Mesotherapy for body contouring. Plast Reconstr Surg. Apr 15 2005;115(5):1420-4. [Medline].
Rohrich RJ. Mesotherapy: what is it? Does it work?. Plast Reconstr Surg. Apr 15 2005;115(5):1425. [Medline].
Rotunda AM, Ablon G, Kolodney MS. Lipomas treated with subcutaneous deoxycholate injections. J Am Acad Dermatol. Dec 2005;53(6):973-8. [Medline].
Berntorp E, Berntorp K, Brorson H, Frick K. Liposuction in Dercum's disease: impact on haemostatic factors associated with cardiovascular disease and insulin sensitivity. J Intern Med. Mar 1998;243(3):197-201. [Medline].
DeFranzo AJ, Hall JH Jr, Herring SM. Adiposis dolorosa (Dercum's disease): liposuction as an effective form of treatment. Plast Reconstr Surg. Feb 1990;85(2):289-92. [Medline].
Rubenstein R, Roenigk HH Jr, Garden JM, Goldberg NS, Pinski JB. Liposuction for lipomas. J Dermatol Surg Oncol. Nov 1985;11(11):1070-4. [Medline].
Bonatus TJ, Alexander AH. Dercum's disease (adiposis dolorosa). A case report and review of the literature. Clin Orthop Relat Res. Apr 1986;251-3. [Medline].
Brodovsky S, Westreich M, Leibowitz A, Schwartz Y. Adiposis dolorosa (Dercum's disease): 10-year follow-up. Ann Plast Surg. Dec 1994;33(6):664-8. [Medline].
Economides NG, Liddell HT. Benign symmetric lipomatosis (Madelung's disease). South Med J. Aug 1986;79(8):1023-5. [Medline].
Gonciarz Z, Mazur W, Hartleb J, Machniak M, Bednarek I, Mazurek U, et al. Interferon alfa-2b induced long-term relief of pain in two patients with adiposis dolorosa and chronic hepatitis C. J Hepatol. Dec 1997;27(6):1141. [Medline].
Held JL, Andrew JA, Kohn SR. Surgical amelioration of Dercum's disease: a report and review. J Dermatol Surg Oncol. Dec 1989;15(12):1294-6. [Medline].
Myhre-Jensen O. A consecutive 7-year series of 1331 benign soft tissue tumours. Clinicopathologic data. Comparison with sarcomas. Acta Orthop Scand. Jun 1981;52(3):287-93. [Medline].
Ruzicka T, Vieluf D, Landthaler M, Braun-Falco O. Benign symmetric lipomatosis Launois-Bensaude. Report of ten cases and review of the literature. J Am Acad Dermatol. Oct 1987;17(4):663-74. [Medline].
Rydholm A, Berg NO. Size, site and clinical incidence of lipoma. Factors in the differential diagnosis of lipoma and sarcoma. Acta Orthop Scand. Dec 1983;54(6):929-34. [Medline].
Solvonuk PF, Taylor GP, Hancock R, Wood WS, Frohlich J. Correlation of morphologic and biochemical observations in human lipomas. Lab Invest. Oct 1984;51(4):469-74. [Medline].
Tallini G, Dal Cin P, Rhoden KJ, Chiapetta G, Manfioletti G, Giancotti V, et al. Expression of HMGI-C and HMGI(Y) in ordinary lipoma and atypical lipomatous tumors: immunohistochemical reactivity correlates with karyotypic alterations. Am J Pathol. Jul 1997;151(1):37-43. [Medline].
Weiss SW. Lipomatous tumors. Monogr Pathol. 1996;38:207-39. [Medline].
lipomatosis, Madelung disease, Dercum disease, adiposis dolorosa, angiolipomas, hibernomas, benign mesenchymal tumors, solitary lipomas, diffuse congenital lipomatosis, benign symmetric lipomatosis, familial multiple lipomatosis
Robert A Moraru, MD, Staff Physician, Department of Dermatology, St Luke's/Roosevelt Hospital Center, Columbia Presbyterian Medical Center
Robert A Moraru, MD is a member of the following medical societies: American Academy of Dermatology
Disclosure: Nothing to disclose.
Janet Fairley, MD, Professor and Head, Department of Dermatology, University of Iowa
Janet Fairley, MD is a member of the following medical societies: American Academy of Dermatology, American Dermatological Association, American Federation for Medical Research, and Society for Investigative Dermatology
Disclosure: Nothing to disclose.
Michael J Wells, MD, Associate Professor, Department of Dermatology, Texas Tech University Health Sciences Center
Michael J Wells, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Dermatology, American Medical Association, and Texas Medical Association
Disclosure: Nothing to disclose.
Rosalie Elenitsas, MD, Associate Professor of Dermatology, University of Pennsylvania School of Medicine; Director, Penn Cutaneous Pathology Services, Department of Dermatology, University of Pennsylvania Health System
Rosalie Elenitsas, MD is a member of the following medical societies: American Society of Dermatopathology
Disclosure: Nothing to disclose.
Catherine Quirk, MD, Clinical Assistant Professor, Department of Dermatology, Brown University
Catherine Quirk, MD is a member of the following medical societies: Alpha Omega Alpha and American Academy of Dermatology
Disclosure: Nothing to disclose.
William D James, MD, Paul R Gross Professor of Dermatology, University of Pennsylvania School of Medicine; Vice-Chair, Program Director, Department of Dermatology, University of Pennsylvania Health System
William D James, MD is a member of the following medical societies: American Academy of Dermatology and Society for Investigative Dermatology
Disclosure: elsevier Royalty Other; american college of physicians Honoraria Other
© 1994-
by Medscape.
All Rights Reserved
(http://www.medscape.com/public/copyright)